Why the study?
It was unknown how plasma biomarkers of Alzheimer's disease interact with white matter hyperintensities on MRI to influence incident dementia risk.
Do plasma biomarkers of Alzheimer's disease and white matter hyperintensities independently predict incident dementia risk in older adults?
Population
1,538 dementia-free participants aged 67-90 years in the ARIC Study
Comparison
Plasma biomarkers of Alzheimer's disease and white matter hyperintensities
Design
Prospective cohort study
Follow-up
10 years
Key result
For every doubling of plasma Aβ42/Aβ40, dementia risk decreased, while p-tau181, NfL, and GFAP increases were associated with higher dementia risk over 10 years.
Authors
Loading...
Supports plasma AD biomarkers plus WMH as independent dementia predictors; extends prior associations but leaves clinical use open pending trials.
Do plasma biomarkers of Alzheimer's disease and white matter hyperintensities independently predict incident dementia risk in older adults?
Plasma biomarkers of Alzheimer's disease and white matter hyperintensities on MRI are independent predictors of incident dementia risk over 10 years.
Kinyanjui et al. (2026) studied this question. For every doubling of plasma Aβ42/Aβ40, dementia risk decreased, while p-tau181, NfL, and GFAP increases were associated with higher dementia risk over 10 years.